Stocks and Investing Stocks and Investing
Wed, July 8, 2020

Raghuram Selvaraju Reiterated (BTAI) at Strong Buy with Increased Target to $120 on, Jul 8th, 2020


Published on 2024-10-27 09:11:41 - WOPRAI, Raghuram Selvaraju
  Print publication without navigation


Raghuram Selvaraju of HC Wainwright & Co., Reiterated "BioXcel Therapeutics, Inc." (BTAI) at Strong Buy with Increased Target from $95 to $120 on, Jul 8th, 2020.

Raghuram has made no other calls on BTAI in the last 4 months.



There is 1 other peer that has a rating on BTAI. Out of the 1 peers that are also analyzing BTAI, 0 agree with Raghuram's Rating of Hold.



This is the rating of the analyst that currently disagrees with Raghuram


  • Geoff Meacham of "B of A Securities" Initiated at Strong Buy and Held Target at $45 on, Wednesday, April 1st, 2020

Contributing Sources